January 5, 2023

Video: The Patient Voice

Watch a few of the ECOG-ACRIN cancer research advocates explain why cancer research is about more than just science
January 5, 2023

Now Enrolling: The BRIDGE research study is evaluating a new treatment approach for patients with early bladder cancer

This study is for patients who have aggressive, high-grade tumors that put them at higher risk of recurrence after treatment
January 5, 2023

Ongoing Trial: The INSPIRE research study is testing a new treatment approach for patients with advanced bladder cancer

This trial is evaluating the effect of adding immune system therapy to the usual treatment (chemotherapy and radiation)
January 5, 2023

Ongoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer

This trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether
January 5, 2023

Trial Results: The TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapy

The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
January 5, 2023

Trial Results: A recent ECOG-ACRIN study finds excellent results for patients with acute lymphoblastic leukemia (ALL)

Adding immunotherapy to standard chemotherapy keeps most patients in remission and improves their survival